Advancing Access to Patient Care: The Importance of Advocacy on the Hill
AdvaMed’s 2024 Medtech Showcase on Capitol Hill featured 37 companies and 40+ innovations, connecting medtech leaders with U.S. policymakers.
Diagnostics
Learn more about our Diagnostics work.
Medtech Goes to Capitol Hill
AdvaMed’s annual Medtech Showcase and Reception on Capitol Hill seeks to inform a core audience: the members of the Congress and their staff who enact the policies that help our…
Carbon Medical Technologies’ BiomarC Tissue Marker Line Achieves EU MDR Certification
April 25, 2025 – Carbon Medical Technologies, Inc. (CMT), a manufacturer of pyrolytic carbon-coated medical devices used in biopsy procedures, for radiation therapy, and to treat stress urinary incontinence, is…
AdvaMed Releases “AI Policy Roadmap” to Guide Congress and Federal Agencies
Washington, D.C.—AdvaMed, the Medtech Association, today released its “AI Policy Roadmap,” a detailed policy outline for Congress and the federal agencies with jurisdiction over medtech to consider in promoting the…
Satio, Nanowear announce partnership offering first, holistic, home-based in vivo- + in vitro diagnostics + drug delivery
BOSTON and NEW YORK, April 14, 2025 /PRNewswire/ — Satio and Nanowear have agreed to partner to advance patient-friendly, home-based diagnostic, and therapeutic care. This collaboration integrates Nanowear’s at-home AI-based nanotechnology biomarker diagnostic platform with Satio’s at-home…
Bipartisan Health Tech Investment Act Will Enhance Patient Access to AI-Enabled Medical Devices
WASHINGTON – AdvaMed, the Medtech Association, today commended Senators Mike Rounds (R-SD) and Martin Heinrich (D-NM) for introducing the Health Tech Investment Act (S. 1399). This landmark bipartisan legislation will…
AdvaMed®’s Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
The Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
The Global Democratization of Point-of-Care & At-Home Diagnostic Testing
One of healthcare’s most extensive and rapidly expanding market segments, Pointof-Care (POC) and at-home rapid diagnostic testing, has become an ever-increasing crucial topic in the medical world since COVID-19 was…
In Congressional Testimony, AdvaMed® Urges Passage of Diagnostic Regulatory Reform
Today, Zach Rothstein, Executive Director of AdvaMedDx®, testified before the House Energy and Commerce Committee, Subcommittee on Health during a hearing on diagnostic test regulation and FDA’s proposed laboratory developed…